About Aditi Ganguly

Aditi is an experienced content developer and financial writer who is passionate about helping investors understand the do's and don'ts of investing.  She has a keen interest in the stock market and has a fundamental approach when analyzing equities.

Aditi's fascination with the stock market began in college, where she majored in Economics, while researching The Great Recession for her thesis.  After graduating, she began her career handling the content requirements for the mutual fund aggregator Groww.  Since then she has become a financial journalist that focuses on writing articles that educate retail investors about the equity markets and the global economy.

Recent Articles By Aditi Ganguly

: FB |  News, Ratings, and Charts

Down 4% in 2021, Will Facebook Stock Rebound?

Social media giant Facebook (FB) is in limelight for all the wrong reasons — from Apple’s (AAPL) new privacy changes affecting FB’s core ad business to a current contentious situation with Australian government regarding payments for news. As a result, the stock has lost 9.3% over the past six months. So, can FB overcome the challenges and recover soon? Read more and we’ll tell you what we think.
: GOOGL |  News, Ratings, and Charts

Up 15% YTD, Will Alphabet Continue to Rally in 2021?

Alphabet (GOOGL) has been the best performing FAANG stock, rising 15% year-to-date. However, an important question about the stock now is in the face of antitrust allegations that are tarnishing its reputation, can GOOGL maintain its rally this year? Read more to find out.
: KEYS |  News, Ratings, and Charts

Should You Buy the Dip in Keysight Technologies Stock?

The price of Keysight Technologies (KEYS), which has a vested interest in the global 5G transformation, dipped slightly over the past month because investors are favoring value stocks ahead of growth investments. Investors are growing more apprehensive about increasing market volatility and an apparent disconnect between the real economy and the stock markets. Question: Will KEYS be able to revive its momentum in the near term amid the prevailing investor mindset? Read on to find out
: WST |  News, Ratings, and Charts

Is West Pharmaceutical Services Stock a Smart Investment?

Medical delivery systems provider West Pharmaceuticals (WST) has retreated slightly over the past month on news of flexibility in the temperature regulations needed to optimize the efficacy of Pfizer’s (PFE) COVID-19 vaccine. However, with a nationwide vaccination program that is now kicking into second gear, optimal transportation and logistics systems will be a necessity. As such, we think WST should rebound in no time. This expectation makes its current price levels a solid entry point for investors seeking to go long in the stock.
: VRTX |  News, Ratings, and Charts

Is Vertex a Great Value Stock to Add to Your Portfolio?

The stocks of Vertex Pharmaceuticals (VRTX), which develops drugs and therapeutics for treatment of critical ailments, has been declining over the past year because the global healthcare industry has been dealing with the ramifications of the COVID-19 pandemic. However, as mass vaccinations are now gradually curbing the spread of the virus, the question has become will VRTX be able to recover its lost momentum this year? Read more to find out.
: SENS |  News, Ratings, and Charts

Up More than 350% YTD, is Senseonics a Good Stock to Buy?

Commercial glucose monitor developer Senseonics (SENS) has soared more than 300% year-to-date driven by investors who are betting on the medical tech company because the pandemic-driven remote lifestyle has exacerbated diabetes, a medical condition. However, SENS has reported losses over the past year, with a substantial decline in revenues and negative cash flows. With bearish analyst sentiment, we think this highly speculative stock is best avoided now.
: NCTY |  News, Ratings, and Charts

Why has The9 Limited Stock Skyrocketed More than 1,500% YTD?

Online gaming company The9 (NCTY) has been making diverse purchases and acquisitions in the cryptocurrency space, allowing the stock to gain more than 2,200% year-to-date. However, as rising regulatory, liquidity, and limited capacity concerns are grappling cryptocurrencies, NCTY’s momentum may be short-lived.
: LZB |  News, Ratings, and Charts

Is La-Z-Boy a Good Stock to Own for a Rebound in the Economy?

La-Z-Boy (LZB) grew significantly in 2020 as the demand for residential furniture rose due to increased spending on home goods. However, a slight dip in the stock over the last month reflects some profit-taking in the sectors that benefitted from the pandemic. Will LZB be able to reach fresh highs or will it underperform ‘reopening stocks’? Read more to find out.
: AMKR |  News, Ratings, and Charts

Does Semiconductor Stock Amkor Technology Belong in Your Portfolio?

U.S.-based semiconductor developer Amkor Technology (AMKR) has witnessed a stellar year in terms of stock price momentum and financial performance. But with a new U.S. presidential administration with a new approach to international trade, a question has presented itself: will changes in U.S. foreign policies hamper or help AMKR’s ability to grow in a highly competitive, global semiconductor industry? Read more to find out.
: GOEV |  News, Ratings, and Charts

Is Electric Vehicle Stock Canoo a Good Investment for 2021?

Canoo (GOEV) is a relatively new player in the EV market. But it is already making headlines regarding its revolutionary ‘Skateboard” technology and “steer by wire” system. While the products look promising, GOEV is still in its development stage, with its commercial vehicle roll-out expected to commence no sooner than 2023. Given these circumstances, the stock looks overvalued with no revenue stream. Let’s discuss more.
Page generated in 0.0202 seconds.